246 related articles for article (PubMed ID: 25595260)
1. Dynamic changes in meningeal inflammation correspond to clinical exacerbations in a murine model of relapsing-remitting multiple sclerosis.
Walker-Caulfield ME; Hatfield JK; Brown MA
J Neuroimmunol; 2015 Jan; 278():112-22. PubMed ID: 25595260
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
3. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
Xie C; Ciric B; Yu S; Zhang GX; Rostami A
J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
Magliozzi R; Columba-Cabezas S; Serafini B; Aloisi F
J Neuroimmunol; 2004 Mar; 148(1-2):11-23. PubMed ID: 14975582
[TBL] [Abstract][Full Text] [Related]
5. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
Columba-Cabezas S; Griguoli M; Rosicarelli B; Magliozzi R; Ria F; Serafini B; Aloisi F
J Neuroimmunol; 2006 Oct; 179(1-2):76-86. PubMed ID: 16870269
[TBL] [Abstract][Full Text] [Related]
6. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Luz A; Fainstein N; Einstein O; Ben-Hur T
Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
[TBL] [Abstract][Full Text] [Related]
7. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
8. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
9. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
[TBL] [Abstract][Full Text] [Related]
10. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.
Christy AL; Walker ME; Hessner MJ; Brown MA
J Autoimmun; 2013 May; 42():50-61. PubMed ID: 23267561
[TBL] [Abstract][Full Text] [Related]
11. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
[TBL] [Abstract][Full Text] [Related]
12. Iron oxide magnetic nanoparticles highlight early involvement of the choroid plexus in central nervous system inflammation.
Millward JM; Schnorr J; Taupitz M; Wagner S; Wuerfel JT; Infante-Duarte C
ASN Neuro; 2013; 5(1):e00110. PubMed ID: 23452162
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
[TBL] [Abstract][Full Text] [Related]
14. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
15. Pertussis toxin promotes relapsing-remitting experimental autoimmune encephalomyelitis in Lewis rats.
Mohajeri M; Sadeghizadeh M; Javan M
J Neuroimmunol; 2015 Dec; 289():105-10. PubMed ID: 26616879
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
[TBL] [Abstract][Full Text] [Related]
17. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
18. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
19. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?
Sayed BA; Christy AL; Walker ME; Brown MA
J Immunol; 2010 Jun; 184(12):6891-900. PubMed ID: 20488789
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
